Porton Fine Chemicals Ltd

SHE:300363 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.57 Billion
CN¥11.48 Billion CNY
Market Cap Rank
#7744 Global
#1364 in China
Share Price
CN¥21.13
Change (1 day)
-0.09%
52-Week Range
CN¥13.56 - CN¥29.41
All Time High
CN¥97.10
About

Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial. It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, produc… Read more

Porton Fine Chemicals Ltd - Asset Resilience Ratio

Latest as of September 2025: 6.85%

Porton Fine Chemicals Ltd (300363) has an Asset Resilience Ratio of 6.85% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
CN¥588.05 Million
Cash + Short-term Investments
Total Assets
CN¥8.58 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2020)

This chart shows how Porton Fine Chemicals Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Porton Fine Chemicals Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥588.05 Million 6.85%
Total Liquid Assets CN¥588.05 Million 6.85%

Asset Resilience Insights

  • Limited Liquidity: Porton Fine Chemicals Ltd maintains only 6.85% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Porton Fine Chemicals Ltd Industry Peers by Asset Resilience Ratio

Compare Porton Fine Chemicals Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA
Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227
Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for Porton Fine Chemicals Ltd (2017–2020)

The table below shows the annual Asset Resilience Ratio data for Porton Fine Chemicals Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2020-12-31 0.09% CN¥4.14 Million CN¥4.50 Billion +0.09pp
2019-12-31 0.01% CN¥224.20K CN¥3.96 Billion -13.03pp
2018-12-31 13.03% CN¥570.21 Million CN¥4.37 Billion +13.00pp
2017-12-31 0.04% CN¥1.06 Million CN¥2.85 Billion --
pp = percentage points